Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03700164
Other study ID # COGT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 11, 2019
Est. completion date November 1, 2019

Study information

Verified date July 2020
Source Maastricht University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to evaluate the effect of cold exposure on an individual's glucose tolerance. Previous research has already shown that 10 days acclimation to a mild cold environment (14-15°C) can enhance insulin sensitivity. However, the duration in the cold environment was 6 hours per day which may not be practical for everyone. Therefore, the present study will investigate the effect of a shorter, and more intense cold exposure on an individual's glucose tolerance. It is hypothesised that cold exposure before consuming a glucose drink will enhance glucose clearance.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date November 1, 2019
Est. primary completion date November 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria of healthy population:

- Signed informed consent.

- White European.

- Male.

- Age 18 - 40 years at the start of the study.

- BMI = 20 and < 30 kg/m2.

Exclusion Criteria of healthy population:

- Smoking.

- Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).

- Cold-acclimated (takes daily cold baths, works in a refrigerated environment, or regular cold water swimmer).

- Unstable body weight (gain or loss > 5kg in last 3 months).

- Currently undertaking a diet.

Inclusion Criteria of prediabetes population:

- Signed informed consent.

- White European.

- Male or female.

- Women should be postmenopausal or use hormonal contraceptives.

- Age 30 - 75 years at the start of the study.

- BMI = 25 and < 35 kg/m2.

- Generally healthy, no medication use that interferes with metabolism. If volunteers need medication (e.g. statin drugs, NSAIDs), it will be reviewed with the dependent physician on an individual basis.

- Impaired fasting glucose (5.6 mM to 6.9 mM) and/or blood glucose values 7.8-11.0 mM 2h after glucose drink consumption during OGTT in screening.

Exclusion Criteria of prediabetes population:

- Smoking.

- Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).

- Cold-acclimated (takes daily cold baths, works in a refrigerated environment, or regular cold water swimmer).

- Unstable body weight (gain or loss > 5kg in last 3 months).

- Currently undertaking a diet.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Temperature
Water-perfused suit.

Locations

Country Name City State
Netherlands Maastricht University Maastricht

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glucose and insulin concentrations in response to an oral glucose load 3 hours post glucose drink, measured 90 minutes after the cold exposure
Secondary Energy expenditure measured using indirect calorimetry 30 minutes before and during the 1 hour of cold exposure
Secondary Core temperature measured using a telemetric pill 30 minutes before and during the 1 hour of cold exposure
Secondary Skin blood flow measured using laser doppler flowmetry 30 minutes before and during the 1 hour of cold exposure
Secondary Shivering activity assessed using surface electromyography 30 minutes before and during the 1 hour of cold exposure
Secondary Systolic and diastolic blood pressure measured using an automatic blood pressure device 30 minutes before and during the 1 hour of cold exposure
Secondary Thermal sensation How warm or cold the participant perceives the environment. Assessed with a visual analogue scale (scale ranging from cold to hot). 30 minutes before and during the 1 hour of cold exposure
Secondary Skin temperature measured using iButtons 30 minutes before and during the 1 hour of cold exposure
Secondary Heart rate measured using chest heart rate monitor sensor 30 minutes before and during the 1 hour of cold exposure
Secondary Comfort How comfortable or uncomfortable the participant perceives the environment. Comfort assessed with a visual analogue scale (scale ranging from very comfortable to very uncomfortable). 30 minutes before and during the 1 hour of cold exposure
See also
  Status Clinical Trial Phase
Completed NCT01267448 - Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Phase 4
Recruiting NCT03775733 - Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia N/A
Completed NCT03482154 - Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT00535600 - Effects of Bariatric Surgery on Insulin
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Recruiting NCT02885909 - Inpatient Blood Glucose Control in Taichung Veterans General Hospital Phase 4
Recruiting NCT02885922 - The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
Withdrawn NCT01488383 - Effect of Stevioside in Postpandrial Glucose in Healthy Adults N/A
Completed NCT02012465 - Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients Early Phase 1
Completed NCT01805414 - Breakfast Nutrition and Inpatient Glycemia N/A
Completed NCT01803568 - Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU N/A
Completed NCT01810952 - The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients Phase 4
Active, not recruiting NCT01247714 - Clinical Evaluation of a Specific Enteral Diet for Diabetics N/A
Not yet recruiting NCT00846144 - The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients N/A
Completed NCT00996099 - Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients N/A
Recruiting NCT00654797 - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2 Phase 2
Completed NCT00468494 - Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia? N/A
Completed NCT00394407 - Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes Phase 4